Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2007 and based in Tel Aviv, Israel, Agate Medical Investments Group focuses on providing growth capital to mature MedTech companies. The firm primarily invests in later-stage medical devices and digital health technologies, managing a portfolio of 10 companies. Agate's approach includes hands-on management and strategic guidance for its portfolio.
Agate invests in healthcare technologies, particularly in Israel and Israel-related markets. The firm targets Seed+ (Extension), Series A, Series B, and Growth Equity stages, providing financial support and strategic guidance to its portfolio companies. Investment areas include medical devices and digital health technologies.
Notable portfolio companies include MST, which develops an image analysis system for surgery; HEALCERION, known for the world's first wireless portable ultrasound device; and AngioLab Inc, focused on pharmaceutical products for angiogenesis-dependent diseases. Other companies include Curaco, People Bio, Lumenis, Iscare, Peptron, Endochoice, and BioInfra.
Email your pitch deck to agate@agate-invest.com for consideration.
Yes, Agate often leads investment rounds, particularly in later-stage funding for its portfolio companies.
Agate is open to follow-on investments, providing additional capital to support the growth of its existing portfolio companies.
Specific fund size details are not disclosed, but Agate focuses on providing substantial growth capital to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.